Oregon Health & Science University Nov 7 2025 A new molecule developed by researchers at Oregon Health & Science University offers a promising avenue to treat intractable cases of triple-negative breast cancer - a form of cancer that is notoriously aggressive and lacks effective treatments. In a study published today in the journal  Cell Reports Medicine , researchers describe the effect of a molecule known as SU212 to inhibit an enzyme that is critical to cancer progression. The research was